In stockResearch use only24h dispatchLot-tracked COA
VaultLabs UAE
TB-500 for UAE laboratories
TB-500 5mg is a sealed 5 mg vial of the standalone thymosin β4 fragment line. The same name appears as a component inside Wolverine 10mg, GLOW 70mg and KLOW 80mg. Those blend certificates describe a combination, not this vial. This page covers the 5 mg fill, the blend boundary and the lot record. Identity context sits on the TB-500 monograph. Supplied for in vitro laboratory research only.
Third-party testedVaultLabs tested · 99.89%
Tested before release
Each catalogue batch is tested by an independent laboratory before release, then checked again on the VaultLabs certificate. The laboratory report for this lot is available on request, and the laboratory is named on that report.
Lot VL-TB500-20260917 · 99.89%
5 mg standalone is not 5 mg inside Wolverine
Wolverine is BPC-157 5 mg plus TB-500 5 mg under one 10 mg total and one lot. A protocol written against this standalone 5 mg vial and executed with Wolverine is also receiving 5 mg of a second sequence. That is an identity change, not a packaging change. The TB-500 and Wolverine comparison sets the documentation boundary.
GLOW and KLOW add further components. None of those records can release a vial labelled TB-500 5mg. Order this SKU when the certificate must describe the fragment alone. Order a blend only when the combination is the object of the work.
Fill mass and the BPC-157 neighbour
BPC-157 10mg is the other single-sequence line most often written onto the same requisition. The fills differ (5 mg versus 10 mg) and the sequences differ. Strength alone will not catch a swap if someone abbreviated both names on a rack label. Print the full catalogue name.
Diluent is not included. With 5 mg in the vial there is little room for a second attempt — fix concentration and volume in the written procedure before opening. The reconstitution basics guide covers the record-keeping side.
Lot records and UAE receiving
Match the printed lot in batch verification or the TB-500 COA index. Confirm standalone TB-500, the 5 mg fill and the lot. A Wolverine, GLOW, KLOW or BPC-157 certificate must not be filed against this unit. Unpublished lots wait on a documentation request.
Store sealed vials at 2–8 °C, protected from light and moisture. Dispatch covers the seven emirates with AED checkout. Log the lot and receipt time and move the parcel into cold storage before the paperwork is finished.
Scope of supply
Cell-migration and actin-binding papers describe model systems. They do not describe this manufacturing lot. VaultLabs makes no statements about tissue, recovery or physiological effects.
TB-500 is supplied for in vitro laboratory research only — not for human or animal use, personal use or medical application — with no administration or preparation guidance for living systems.
Frequently asked questions
No. Those blends include a TB-500 component under a composite lot. This SKU is a standalone 5 mg vial with its own certificates.
That is the standalone catalogue fill. Wolverine’s 10 mg name is a two-component total, not 10 mg of TB-500. Do not treat the numbers as interchangeable.
No. The sequences are different and the lots are independent. Match the lot printed on the vial in front of you.
No. It is supplied for in vitro laboratory research only, with no administration guidance and no claims about effects in living systems.
All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.